Press Releases

Distributed: Feb 21, 2011

Alerts Login

View in Other Languages 3198 1905 1879 1585 1395 1337 1297 1201 1135 1097 951 

Sydney, Feb 21, 2011 (ABN Newswire) - Prima BioMed Limited (ASX:PRR) today announced that there has been an agreement for strategy and design of the Phrase III clinical trial for the CVac(TM) immunotherapy therapeutic ovarian cancer vaccine. The agreement comes after the European regulator, the European Medicines Agency advised that Scientific Advice for the Phase III trial had successfully been granted. Receiving Scientific Advice is a significant milestone in the timeline progression for CVac(TM)'s global registration. Prima can now move forward and begin preparations for patient enrolment into the trial. If the trial is successful, CVac(TM) will become the world's first ovarian cancer immunotherapy treatment.

Redstone Resources Limited (ASX:RDS) reported further significant assay results from recent reverse circulation drilling at its 100% owned Tollu copper project in Western Australia. Copper sulphide mineralisation has been extended to over 200m strike length and to a depth of 253m, highlighting the potential to increase the size of the mineralised body. Further drilling is scheduled to commence in May 2011 to extend the current mineralisations and test other Cu-rich areas.

Western Desert Resources Limited (ASX:WDR) today reported that assay results from drilling at its Roper Bar Iron Ore Project in the Northern Territory have identified further high grade direct shipping iron ore. Five holes recoded intersections with grades greater than 60% Fe. Iron ore mineralization extends over 1200 metres strike length. The Company will continue to assess the area's potential for commercial mining operations.

Canyon Resources Limited (ASX:CAY) has accelerated its exploration programme on its gold projects in Burkina Faso, following the discovery of several new prospects on its recently acquired permits. Since late November 2010, the Company has drilled 6,616 meters and taken over 1,300 samples with highest grades up to 6.16 g/t Au. The Company is to commence its maiden reverse circulation drill programme in late March or early April 2011.

Contact

Asia Business News
Tel: +61-2-9247-4344
http://www.abnnewswire.net

  Related Companies

>>>              Canyon Resources Limited
>>>              Prima Biomed Ltd
>>>              Redstone Resources Limited
>>>              Western Desert Resources Limited

  Related Industry Topics:

Metals | Biotech | Clinical Trials | Drugs & OTC | Financial General | Health & Pharm General | Materials General | Mining | Australian Economy | Gold | Copper | Iron Ore | Market Reports | 

  This Page Viewed:  (Last 7 Days: 250) (Last 30 Days: 1250) (Since Published: 31980) 

31980 19050 18790 15850 13950 13370 12970 12010 11350 10970 9510  (169800)

Events & Exhibitions

Site Search

 
 ENGLISH   All Languages

Upcoming WebCasts

Mr Mark Paton CEO
Cue Energy Resources
Tuesday, June 12, 2012

Mr Alan Hopkins CEO
Pan Asia Corporation
Tuesday, June 12, 2012

Mr Barry Dawes
Martin Place Securities
Tuesday, June 12, 2012

Dr Andrea Grant CEO
Living Cell Technologies
Monday, July 02, 2012


Canyon Resources Limited
2011.11.02  12:00 Asian Activities Report for November 2, 2011: DuluxGroup (ASX:DLX) to Merge Business with Camelpaint for Future Expansion in China
2011.09.08  12:07 Asian Activities Report for September 8, 2011: Encounter Resources (ASX:ENR) Announce Significant Recent Advances at the Yeneena Copper Project
2011.08.12  12:00 Asian Activities Report for August 12, 2011: Strategic Elements (ASX:SOR) Announce Rare Earths Expansion to Ireland and Immediate Focus on New Zealand
2011.04.07  12:00 Asian Activities Report for April 7, 2011: Uranex NL (ASX:UNX) Commence Exploration At Songea Coal Project In Tanzania
2010.12.10  13:30 Australian Market Report of December 10, 2010: Golden West Resources (ASX:GWR) to Acquire Highly Prospective Gold Tenement in Senegal
Prima Biomed Ltd
2011.04.27  09:58 Sino Gas And Energy Holdings Limited (ASX:SEH) Secures A$29.4M Funding To Increase Gas Sales
2008.03.19  14:18 Prima Biomed (ASX:PRR) Receives GAP Report For Cancer Product Toward US FDA
2006.05.16  14:15 Prima Biomed Ltd Audio WebCast  PRIMA BIOMED LTD ASX: PRR - Interim Results - Clinical Trial for Ovarian Cancer Drug; Mr Eugene Kopp, Executive Chairman
2006.05.16  14:00 Prima Biomed Ltd Audio WebCast  PRIMA BIOMED LTD ASX: PRR - Interim Results - Clinical Trial for Ovarian Cancer Drug; Dr George Mihaly, Chair of Scientific Advisory Panel
Redstone Resources Limited
2011.09.23  12:00 Asian Activities Report for September 23, 2011: Redstone Resources (ASX:RDS) Report Significant Drilling Results from Tollu Copper Nickel Project
Webcast Your Annual General Meeting

Mobile Video TV

qrcode
Scan with your Mobile Phone to view ABN Newswire Video Channel on Mobile
 
City Index - A Better Way To Trade